Nina Wagner‐Johnston

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

Ramiro Garzon, Michael R. Savona, Rachid Baz et al. · Blood · 2017 · 153 citations · Full text

Medicine, Oncology, Pharmacology +10

ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP

Grzegorz S. Nowakowski, Fangxin Hong, David W. Scott et al. · Hematological Oncology · 2019 · 35 citations

Medicine, Hematology, Oncology +16

Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy

Nicole A. Carreau, Philippe Armand, Reid W. Merryman et al. · British Journal of Haematology · 2020 · 24 citations · Full text

Medicine, Immunology, Oncology +17

Checkpoint Inhibitor Therapy and Graft Versus Host Disease in Allogeneic Bone Marrow Transplant Recipients of Haploidentical and Matched Products with Post-Transplant Cyclophosphamide.

Laura Schoch, Ivan Borrello, Ephraim J. Fuchs et al. · Blood · 2016 · 21 citations

Life Sciences, Hematology, Immunology +17

Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma

Reid W. Merryman, Nicole A. Carreau, Ranjana H. Advani et al. · The Oncologist · 2020 · 18 citations · Full text

Life Sciences, Immunology, Oncology +17